drugset / Trial / NCT00584532

Effects of a Genistein Concentrated Polysaccharide (GCP) for Prostate Cancer on Active Surveillance.

NCT00584532 ↗

Phase 2/3 Completed 66 enrolled University of California, Davis
RandomizedCrossoverDouble-blindTreatment

Summary

Genistein Combined Polysaccharide (GCP) may play a role as a secondary chemopreventive agent in the treatment of localized prostate cancer.

Timeline

Start
2003-11
Primary completion
2005-12
Completion
2007-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Genistein Combined Polysaccharide Unknown 5 g Oral

Indications